Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 18, Issue 1, Pages 40-55
Publisher
Springer Science and Business Media LLC
Online
2021-11-04
DOI
10.1038/s41582-021-00581-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Axon‐myelin unit blistering as early event in MS normal appearing white matter.
- (2021) Antonio Luchicchi et al. ANNALS OF NEUROLOGY
- BTK blockers make headway in multiple sclerosis
- (2021) Elie Dolgin NATURE BIOTECHNOLOGY
- Siponimod and Cognition in Secondary Progressive Multiple Sclerosis
- (2021) Ralph H.B. Benedict et al. NEUROLOGY
- Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis
- (2021) Dennis Brown et al. Neurotherapeutics
- Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
- (2021) Robert J Fox et al. Multiple Sclerosis Journal
- Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition
- (2021) Pavan Bhargava et al. BRAIN
- Hydroxychloroquine for Primary Progressive Multiple Sclerosis
- (2021) Marcus W. Koch et al. ANNALS OF NEUROLOGY
- Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system
- (2020) Khalil S. Rawji et al. ACTA NEUROPATHOLOGICA
- Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions
- (2020) Nina L Fransen et al. BRAIN
- New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis
- (2020) Pablo Villoslada et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
- (2020) Anna He et al. LANCET NEUROLOGY
- Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation
- (2020) Andrew S. Mendiola et al. NATURE IMMUNOLOGY
- The 2013 clinical course descriptors for multiple sclerosis
- (2020) Fred D. Lublin et al. NEUROLOGY
- Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis
- (2020) Simon Licht-Mayer et al. ACTA NEUROPATHOLOGICA
- Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
- (2020) Sebastian Torke et al. ACTA NEUROPATHOLOGICA
- Molecular signature of slowly expanding lesions in progressive multiple sclerosis
- (2020) Katharina Jäckle et al. BRAIN
- Mechanisms underlying progression in multiple sclerosis
- (2020) Martina Absinta et al. CURRENT OPINION IN NEUROLOGY
- Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells
- (2020) Naif O. Al-Harbi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lipoic acid modulates inflammatory responses of monocytes and monocyte‐derived macrophages from healthy and relapsing‐remitting multiple sclerosis subjects
- (2020) Sarah E Fiedler et al. IMMUNOLOGY AND CELL BIOLOGY
- Remyelination in multiple sclerosis: from basic science to clinical translation
- (2020) Catherine Lubetzki et al. LANCET NEUROLOGY
- Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis
- (2020) Laura Starost et al. ACTA NEUROPATHOLOGICA
- Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis
- (2020) Marcus Sucksdorff et al. BRAIN
- Astrocyte Crosstalk in CNS Inflammation
- (2020) Mathias Linnerbauer et al. NEURON
- Revisiting remyelination: Towards a consensus on the regeneration of CNS myelin
- (2020) Robin J.M. Franklin et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Single-cell mass cytometry reveals complex myeloid cell composition in active lesions of progressive multiple sclerosis
- (2020) Chotima Böttcher et al. Acta Neuropathologica Communications
- Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI
- (2020) Assunta Dal-Bianco et al. BRAIN
- Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis
- (2020) Bruce AC Cree et al. Multiple Sclerosis Journal
- Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis
- (2020) Stefan A. Berghoff et al. NATURE NEUROSCIENCE
- Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study
- (2020) Robert T. Naismith et al. NEUROLOGY
- Neuroinflammation in the normal-appearing white matter (NAWM) of the multiple sclerosis brain causes abnormalities at the nodes of Ranvier
- (2020) Patricia Gallego-Delgado et al. PLOS BIOLOGY
- Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
- (2019) J. William L. Brown et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
- (2019) Hans Lassmann Frontiers in Immunology
- Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis
- (2019) Alexandra M. Nicaise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association between pathological and MRI findings in multiple sclerosis
- (2019) Massimo Filippi et al. LANCET NEUROLOGY
- The benefits of neuroinflammation for the repair of the injured central nervous system
- (2019) Heather Y. F. Yong et al. Cellular & Molecular Immunology
- Bassoon proteinopathy drives neurodegeneration in multiple sclerosis
- (2019) Benjamin Schattling et al. NATURE NEUROSCIENCE
- Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis
- (2019) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential mechanisms of action related to the efficacy and safety of cladribine
- (2019) David Baker et al. Multiple Sclerosis and Related Disorders
- Promoting remyelination in multiple sclerosis
- (2019) Nick Cunniffe et al. JOURNAL OF NEUROLOGY
- Immunological Aspects of Approved MS Therapeutics
- (2019) Paulus S. Rommer et al. Frontiers in Immunology
- Potential role of iron in repair of inflammatory demyelinating lesions
- (2019) Nathanael J. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process
- (2019) Azadeh Yazdi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
- (2019) Simon Faissner et al. NATURE REVIEWS DRUG DISCOVERY
- When encephalitogenic T cells collaborate with microglia in multiple sclerosis
- (2019) Yifei Dong et al. Nature Reviews Neurology
- Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
- (2019) Martina Absinta et al. JAMA Neurology
- Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
- (2019) Kjetil Bjornevik et al. JAMA Neurology
- Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells
- (2019) Björn Neumann et al. Cell Stem Cell
- Cerebellar volume loss in radiologically isolated syndrome
- (2019) Ilena C George et al. Multiple Sclerosis Journal
- 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions
- (2019) Jonathan Zurawski et al. Multiple Sclerosis Journal
- Dimethyl Fumarate Reduces Microglia Functional Response to Tissue Damage and Favors Brain Iron Homeostasis
- (2019) Francesca Pagani et al. NEUROSCIENCE
- Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis
- (2018) Sabina Luchetti et al. ACTA NEUROPATHOLOGICA
- Deep gray matter volume loss drives disability worsening in multiple sclerosis
- (2018) Arman Eshaghi et al. ANNALS OF NEUROLOGY
- Progression of regional grey matter atrophy in multiple sclerosis
- (2018) Arman Eshaghi et al. BRAIN
- Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
- (2018) Clara Matute-Blanch et al. BRAIN
- Ibrutinib brain distribution: a preclinical study
- (2018) Lauriane Goldwirt et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity
- (2018) Jasper Rip et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Emerging drugs for primary progressive multiple sclerosis
- (2018) Ram Narendra Narayan et al. EXPERT OPINION ON EMERGING DRUGS
- Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis
- (2018) Graham Campbell et al. FEBS LETTERS
- Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis
- (2018) Joshua D. George et al. JOURNAL OF NEUROIMMUNOLOGY
- Teriflunomide promotes oligodendroglial differentiation and myelination
- (2018) Peter Göttle et al. Journal of Neuroinflammation
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Anomalies Characteristic of Central Nervous System Demyelination
- (2018) Christine Lebrun et al. NEUROLOGIC CLINICS
- Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis
- (2018) Robert Zivadinov et al. RADIOLOGY
- Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models
- (2018) Huichun Tong et al. Frontiers in Molecular Neuroscience
- Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
- (2018) Jesper Hagemeier et al. NeuroImage-Clinical
- Effects of lipoic acid on walking performance, gait, and balance in secondary progressive multiple sclerosis
- (2018) Bryan D. Loy et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
- (2018) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
- (2018) Colm Elliott et al. Multiple Sclerosis Journal
- Treatment of multiple sclerosis — success from bench to bedside
- (2018) Mar Tintore et al. Nature Reviews Neurology
- Progressive iron accumulation across multiple sclerosis phenotypes revealed by sparse classification of deep gray matter
- (2017) Ahmed M. Elkady et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
- (2017) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Cortical Remyelination Is Heterogeneous in Multiple Sclerosis
- (2017) Eva M.M. Strijbis et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
- (2017) Tomas Kalincik et al. LANCET NEUROLOGY
- Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
- (2017) Dennis Chan et al. LANCET NEUROLOGY
- Alpha-lipoic acid mitigates toxic-induced demyelination in the corpus callosum by lessening of oxidative stress and stimulation of polydendrocytes proliferation
- (2017) Nima Sanadgol et al. METABOLIC BRAIN DISEASE
- The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination
- (2017) Abdelkrim Mannioui et al. Multiple Sclerosis Journal
- Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
- (2017) Simon Faissner et al. Multiple Sclerosis Journal
- In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis
- (2017) In-Young Choi et al. Multiple Sclerosis Journal
- Remyelination therapies: a new direction and challenge in multiple sclerosis
- (2017) Jason R. Plemel et al. NATURE REVIEWS DRUG DISCOVERY
- Achievements and obstacles of remyelinating therapies in multiple sclerosis
- (2017) Martin Stangel et al. Nature Reviews Neurology
- Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system
- (2017) I. Micu et al. NATURE REVIEWS NEUROSCIENCE
- Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
- (2017) Sinead O'Sullivan et al. NEUROPHARMACOLOGY
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
- (2017) Simon Faissner et al. Nature Communications
- The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination
- (2017) Abdelkrim Mannioui et al. Multiple Sclerosis Journal
- Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
- (2017) Simon Faissner et al. Multiple Sclerosis Journal
- In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis
- (2017) In-Young Choi et al. Multiple Sclerosis Journal
- Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity
- (2017) Alexander N. R. Weber et al. Frontiers in Immunology
- Lovastatin Induces Neuroprotection Through Tumor Necrosis Factor Receptor 2 Signaling Pathways
- (2017) Amalia M. Dolga et al. JOURNAL OF ALZHEIMERS DISEASE
- Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
- (2016) Assunta Dal-Bianco et al. ACTA NEUROPATHOLOGICA
- Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
- (2016) Benedetta Bodini et al. ANNALS OF NEUROLOGY
- Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions
- (2016) Hans Lassmann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Oxidative injury in multiple sclerosis cerebellar grey matter
- (2016) Kevin Kemp et al. BRAIN RESEARCH
- The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy
- (2016) Leslie J. Crofford et al. Expert Review of Clinical Immunology
- White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis
- (2016) Niels Bergsland et al. JOURNAL OF NEUROIMAGING
- Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice
- (2016) Yafei Sun et al. JOURNAL OF NEUROIMMUNOLOGY
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
- (2016) Richard Macrez et al. LANCET NEUROLOGY
- Astrocytes in multiple sclerosis
- (2016) Samuel K Ludwin et al. Multiple Sclerosis Journal
- Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis
- (2016) In-Young Choi et al. Multiple Sclerosis Journal
- Astrocytes in multiple sclerosis
- (2016) Samuel K Ludwin et al. Multiple Sclerosis Journal
- Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis
- (2016) In-Young Choi et al. Multiple Sclerosis Journal
- Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome
- (2015) Orhun H. Kantarci et al. ANNALS OF NEUROLOGY
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
- (2015) Josa M. Frischer et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis
- (2015) Mika Komori et al. ANNALS OF NEUROLOGY
- How microglia kill neurons
- (2015) Guy C. Brown et al. BRAIN RESEARCH
- Dimethyl fumarate in relapsing–remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety
- (2015) Duvyanshu Dubey et al. Expert Review of Neurotherapeutics
- Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
- (2015) Marcus W. Koch et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Exploring the origins of grey matter damage in multiple sclerosis
- (2015) Massimiliano Calabrese et al. NATURE REVIEWS NEUROSCIENCE
- Dimethyl fumarate in relapsing–remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety
- (2015) Duvyanshu Dubey et al. Expert Review of Neurotherapeutics
- Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome
- (2014) Paolo Giannetti et al. BRAIN
- Relationship between iron accumulation and white matter injury in multiple sclerosis: a case–control study
- (2014) Eytan Raz et al. JOURNAL OF NEUROLOGY
- Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
- (2014) Lukas Haider et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Iron in multiple sclerosis: roles in neurodegeneration and repair
- (2014) Erin Stephenson et al. Nature Reviews Neurology
- Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide
- (2014) Joan Ní Gabhann et al. PLoS One
- Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
- (2013) Shailender Singh et al. ACTA NEUROPATHOLOGICA
- Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models
- (2013) Amanda Boyd et al. ACTA NEUROPATHOLOGICA
- Iron and neurodegeneration in the multiple sclerosis brain
- (2013) Simon Hametner et al. ANNALS OF NEUROLOGY
- Disease-specific molecular events in cortical multiple sclerosis lesions
- (2013) Marie Therese Fischer et al. BRAIN
- Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells
- (2013) Pamela Urrutia et al. JOURNAL OF NEUROCHEMISTRY
- Fingolimod phosphate promotes the neuroprotective effects of microglia
- (2013) Hiromi Noda et al. JOURNAL OF NEUROIMMUNOLOGY
- Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
- (2013) Aran Groves et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome
- (2013) M. L. Stromillo et al. NEUROLOGY
- Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
- (2012) Jack Antel et al. ACTA NEUROPATHOLOGICA
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
- (2012) Marie T. Fischer et al. BRAIN
- Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
- (2012) C. Algire et al. Cancer Prevention Research
- Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia
- (2012) Vikramjeet Singh et al. Journal of Neuroimmune Pharmacology
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla
- (2011) F. Bagnato et al. BRAIN
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Oxidative damage in multiple sclerosis lesions
- (2011) L. Haider et al. BRAIN
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis
- (2011) S Rossi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
- (2011) Hye Jung Kim et al. FASEB JOURNAL
- Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis
- (2011) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
- (2011) Ivana Nikić et al. NATURE MEDICINE
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords
- (2010) Géraldine Androdias et al. ANNALS OF NEUROLOGY
- Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
- (2010) Graham R. Campbell et al. ANNALS OF NEUROLOGY
- Demyelination versus remyelination in progressive multiple sclerosis
- (2010) Stephan Bramow et al. BRAIN
- The natural history of secondary progressive multiple sclerosis
- (2010) M. Koch et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Diffusely Abnormal White Matter in Chronic Multiple Sclerosis
- (2009) Alexandra Seewann et al. ARCHIVES OF NEUROLOGY
- Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis
- (2009) N. Nath et al. JOURNAL OF IMMUNOLOGY
- Remyelination capacity of the MS brain decreases with disease chronicity
- (2009) T. Goldschmidt et al. NEUROLOGY
- Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
- (2008) T. Kuhlmann et al. BRAIN
- Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up
- (2008) L. Guasti et al. EUROPEAN HEART JOURNAL
- Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression
- (2008) J. van Horssen et al. FREE RADICAL BIOLOGY AND MEDICINE
- A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis
- (2008) Howard L. Weiner JOURNAL OF NEUROLOGY
- Inhibition of Rho Family Functions by Lovastatin Promotes Myelin Repair in Ameliorating Experimental Autoimmune Encephalomyelitis
- (2008) A. S. Paintlia et al. MOLECULAR PHARMACOLOGY
- Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice
- (2008) Jing Zhang et al. NEUROBIOLOGY OF DISEASE
- FTY720 modulates human oligodendrocyte progenitor process extension and survival
- (2007) Veronique E. Miron et al. ANNALS OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now